Infuse Bone Graft Claim Can’t Be Based On Sales Reps’ Prediction Of Approval
(August 25, 2015, 12:57 PM EDT) -- ST. LOUIS — Alleged statements by Medtronic Inc. sales representatives that an off-label use of its Infuse bone graft would be approved in the future is an opinion and not a...
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login